Tokio Marine Nichido and Eisai Co-Develop Industry’s First “Dementia Care Support Insurance”
TOKYO, Sep 28, 2023 – (JCN Newswire) – TOKYO, Sept 28, 2023 – (JCN Newswire)…
TOKYO, Sep 28, 2023 – (JCN Newswire) – TOKYO, Sept 28, 2023 – (JCN Newswire)…
LOS ANGELES–(BUSINESS WIRE)–KOCOWA+, the premier destination for Korean entertainment in the Americas, is launching a…
CloudFabrix builds market momentum with Telcos and MSPs and launches a GSI partner program PLEASANTON,…
LONDON & NEW YORK & HONG KONG–(BUSINESS WIRE)–Options Technology, the leading provider of cloud-enabled managed…
CAMPBELL, Calif.–(BUSINESS WIRE)–8×8, Inc. (NASDAQ: EGHT), a leading integrated cloud contact center and unified communications…
MATFORS, Sweden, Sept. 28, 2023 (GLOBE NEWSWIRE) — NorthX Biologics AB (“NorthX”) is proud to…
Target dose of 12 mg demonstrates robust early activity and manageable tolerability profile:– 63% ORR,…
Novozymes is excited to offer Vertera® ProBite as a game-changing solution to the plant-based meat…
Stuttgart, 28th of September 2023 – Virtune, a regulated crypto ETP (“Exchange Traded Product”) issuer,…
Terranet is moving closer to the milestone of the first prototype of Terranet’s unique Advanced…
TOKYO, Sep 28, 2023 – (JCN Newswire) – Field trial route TOKYO, Sept 28, 2023…
TOKYO, Sep 28, 2023 – (JCN Newswire) – The Campaign Website at “FUN! JAPAN” TOKYO,…
Hong Kong, Sept 28, 2023 – (ACN Newswire) – AEON Credit Service (Asia) Company Limited…
Hong Kong, Sept 28, 2023 – (ACN Newswire) – China’s largest platform-centric decision-making AI company[1]…
Hong Kong, Sept 28, 2023 – (ACN Newswire) – On September 12th, Apple’s annual fall…
Nine in ten US employees rate their mental health positively due to a balanced workload…
Proposed capital increase with preferential subscription rights, to be carried out in January 2024 to…
Strong H1 sales growth (+101%) and significant reduction in current operating loss (-78%) Generated YTD…
Revenue of €4.3 million in the first half of 2023, +4% compared with H1 2022…
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology…